Oncology & Cancer

Cervical vaccine also protects against anal cancer risk

A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.

Oncology & Cancer

Clinical trials show promise in leukemia

Two drugs that target different mutations showed encouraging results in treating leukemia, according to recent clinical trials published in the New England Journal of Medicine (NEJM) and The Lancet Oncology.

Oncology & Cancer

Cancer incidence predicted to increase 75 percent by 2030

The global cancer burden is set to surge more than 75% by 2030, according to new research published Online First in the Lancet Oncology. The rise is predicted to be even larger in the developing world, with the poorest countries ...

Oncology & Cancer

New blood test improves prostate cancer screening

Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a ...

Oncology & Cancer

Most anal lesions don't cause cancer in men, research shows

(HealthDay) -- Anal human papillomavirus (HPV) infection and precancerous lesions are common among gay and bisexual men, but most of these cases will not progress to anal cancer, a new analysis of earlier research shows.

Oncology & Cancer

Height clue to cancer risk

(Medical Xpress) -- Taller people are at increased risk of a wide range of cancers, according to new research led by Oxford University.

page 2 from 12